Precipio Customer American Oncology Network (AON) Selected To Present HemeScreen® Technology Case Study At Industry Leading Clinical Laboratory Conference
NEW HAVEN, CT – (Apr 26th, 2022) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited [...]